共 652 条
[1]
Yachida S(2010)Distant metastasis occurs late during the genetic evolution of pancreatic cancer Nature 467 1114-1117
[2]
Jones S(2011)Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils EMBO Mol Med 3 623-636
[3]
Bozic I(2016)Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature Crit Rev Oncol Hematol 100 107-116
[4]
Antal T(2016)Genomic aberrations in crizotinib resistant lung adenocarcinoma samples identified by transcriptome sequencing PLoS One 11 e0153065-33
[5]
Leary R(2015)Genomic aberrations guiding treatment of non-small cell lung cancer patients Cancer Treat Commun 4 23-348
[6]
Fu B(2017)The different mechanisms of Cancer drug resistance: a brief review Adv Pharm Bull 7 339-151
[7]
Kamiyama M(2017)Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors Carcinogenesis 38 144-427
[8]
Hruban RH(2018)Generation of a PAX6 knockout glioblastoma cell line with changes in cell cycle distribution and sensitivity to oxidative stress BMC Cancer 18 496-E1577
[9]
Eshleman JR(2014)In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system Nature 516 423-54
[10]
Nowak MA(2018)Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer Proc Natl Acad Sci 115 E1570-296